Thought Leadership


Investment Insights: How we see the world in 2023 – ETF Partners
Drawing on over 15 years of experience leading the market in sustainable investing, ETF Partners has published its latest investment paper, outlining the…
Only members with restricted access (ie. academics, asset owners, government and regulatory, independent advisers/trustees and sponsoring employers) can view this article. Please login or join to view. If your organisation is already a member, please contact us for access.
Ozempic – is Novo Nordisk’s diabetes and weight loss drug a miracle or a menace? – WHEB
The public reaction to Ozempic has been frenzied. Videos on TikTok tagged with #Ozempic have nearly 900 million views. Entertainment press is rife with…
Only members with restricted access (ie. academics, asset owners, government and regulatory, independent advisers/trustees and sponsoring employers) can view this article. Please login or join to view. If your organisation is already a member, please contact us for access.